Estimating historical disease burden and the impact of vaccination by influenza type and subtype in the United States, 2016-2020
Morris, S. E.; Mathis, S. M.; Chung, J. R.; Flannery, B.; O'Halloran, A.; Cummings, C. N.; Garg, S.; Lu, P.-J.; Santibanez, T. A.; Reed, C.; Biggerstaff, M.; Iuliano, A. D.
Show abstract
Seasonal influenza causes substantial morbidity and mortality in the United States. The U.S. Centers for Disease Control and Prevention (CDC) uses a compartmental framework to estimate the annual disease burden and burden prevented by vaccination for all influenza types and subtypes combined. However, these estimates do not capture underlying shifts in disease burden caused by different circulating influenza virus types or subtypes. We demonstrate an extension of the current framework to estimate disease burden and burden prevented by vaccination for influenza A virus subtypes A(H1N1) and A(H3N2), and influenza type B viruses. We applied this method to data from the 2016/17 to 2019/20 seasons that include age- and virus-specific hospitalizations and vaccine effectiveness estimates, and age-specific vaccination coverage estimates. We estimated the number of symptomatic illnesses, medically-attended illnesses, hospitalizations, and deaths caused by each virus, and the corresponding number prevented by vaccination. Disease burden and vaccine-prevented burden varied substantially by season, age, and virus type or subtype. The greatest disease burden was estimated in 2017/18, whereas 2019/20 had the greatest burden prevented by vaccination. Influenza A viruses contributed most to disease burden in all seasons. Vaccination against influenza B viruses prevented the largest percentage of hospitalizations among children and adults <65 years, whereas vaccination against A(H1N1) prevented the largest percentage of hospitalizations among adults [≥]65 years. Overall, our results highlight complex variability in influenza disease burden by season, age, and virus type and subtype. These findings can be used to improve understanding of the factors impacting influenza disease burden each season and to enhance communications of the value of influenza vaccination. HighlightsO_LIEstimates of disease burden and vaccine-prevented burden inform influenza guidance. C_LIO_LIContributions to burden from each virus type and subtype vary by season and age. C_LIO_LIA(H3N2) caused the greatest total disease burden from the 2016/17 to 2019/20 seasons. C_LIO_LIChildren <18 years experienced greater influenza B burden compared with other ages. C_LIO_LIVaccination against A(H1N1) and B prevented the greatest percentage of severe disease. C_LI
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Detection of novel influenza viruses through community and healthcare testing: Implications for surveillance efforts in the United States 93%
- The role of viral interference in shaping RSV epidemics following the 2009 H1N1 influenza pandemic 93%
- Increased Influenza Severity in Children in the Wake of SARS-CoV-2 93%
Similar papers in this journal
- Age-seroprevalence curves for the multi-strain structure of influenza A virus 94%
- Characterizing the epidemiological interactions between influenza and respiratory syncytial viruses and their implications for epidemic control 94%
- Epigraph Hemagglutinin Vaccine Induces Broad Cross-reactive Immunity Against Swine H3 Influenza Virus 94%
Similar papers in this journal
- Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection? 94%
- The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: influenza incidence, seasonality, and transmission 94%
- Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 93%
Similar papers in this journal
- Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States 95%
- Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study 94%
- Transient increased risk of influenza infection following RSV infection in South Africa; findings from the PHIRST study, South Africa, 2016-2018 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.